Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leukocyte subsets in treatment-resistant major depression.

M Kubera1, D Van Bockstaele, M Maes

  • 1Department of Endocrinology, Institute of Pharmacology, Polish Academy of Sciences, Kraków.

Polish Journal of Pharmacology
|May 19, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuroimmunological aspects of the alterations in zinc homeostasis in the pathophysiology and treatment of depression.

Acta neuropsychiatrica·2016
Same author

Brain glucose metabolism in an animal model of depression.

Neuroscience·2015
Same author

Prenatal administration of lipopolysaccharide induces sex-dependent changes in glutamic acid decarboxylase and parvalbumin in the adult rat brain.

Neuroscience·2014
Same author

Prenatal stress leads to changes in IGF-1 binding proteins network in the hippocampus and frontal cortex of adult male rat.

Neuroscience·2014
Same author

Antidepressants attenuate the dexamethasone-induced decrease in viability and proliferation of human neuroblastoma SH-SY5Y cells: a involvement of extracellular regulated kinase (ERK1/2).

Neurochemistry international·2013
Same author

In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes.

Acta psychiatrica Scandinavica·2012

Treatment-resistant depression is linked to increased T helper cells and a higher CD4+/CD8+ ratio, suggesting immune system activation and thymus dysfunction in patients. Further research into these immune markers may offer new therapeutic avenues.

Area of Science:

  • Immunology
  • Neuroscience
  • Psychiatry

Background:

  • Major depressive disorder (MDD) is a prevalent mental health condition.
  • Treatment-resistant depression (TRD) poses a significant clinical challenge.
  • Immune system dysregulation has been implicated in mood disorders.

Purpose of the Study:

  • To investigate T cell subset differences in patients with treatment-resistant major depression compared to healthy controls.
  • To explore potential links between immune activation and thymus function in TRD.

Main Methods:

  • Analysis of peripheral blood samples.
  • Flow cytometry to quantify T cell populations (CD4+ T cells, CD4+CD8+ T cells).
  • Calculation of CD4+/CD8+ T cell ratios.

Related Experiment Videos

Main Results:

  • Patients with TRD exhibited a significantly higher percentage of helper CD4+ T cells.
  • An increased proportion of immature double positive CD4+CD8+ T cells was observed in TRD patients.
  • A higher CD4+/CD8+ ratio was found in the blood of individuals with TRD compared to healthy controls.

Conclusions:

  • Findings suggest an activated T helper immune response in patients with treatment-resistant depression.
  • The observed T cell profile indicates a potential disturbance in thymus function.
  • These immunological alterations may represent novel biomarkers or therapeutic targets for TRD.